Merck & Company Inc (MRK)

TradeGate
Currency in EUR
Disclaimer
99.90
-0.30
(-0.30%)
Closed
Day's Range
99.10
100.40
52 wk Range
87.90
109.20
Volume
7,921
Bid/Ask
99.60 / 99.90
Prev. Close
100.2
Open
100.2
Day's Range
99.1-100.4
52 wk Range
87.9-109.2
Volume
7,921
Average Vol. (3m)
5,255
1-Year Change
11.96%
Shares Outstanding
2,537,521,169
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
122.82
Upside +16.00%

People Also Watch

510.51
UNH
+0.87%
833.89
AVGO
+0.58%
552.21
LLY
+0.30%
108.29
ORCL
-0.68%
176.08
AAPL
+0.74%
How do you feel today about MRK?
Vote to see community's results!
or

Merck & Company Inc Company Profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Employees
68000

Income Statement